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Bacterial surface polysaccharides play significant roles in fitness and virulence. In
Gram-negative bacteria such as Escherichia coli, major surface polysaccharides are
lipopolysaccharide (LPS) and capsule, representing O- and K-antigens, respectively.
There are multiple combinations of O:K types, many of which are well-characterized
and can be related to ecotype or pathotype. In this investigation, we have identified
a novel O:K permutation resulting through a process of major genome reorganization
in a clade of E. coli. A multidrug-resistant, extended-spectrum β-lactamase (ESBL)-
producing strain – E. coli 26561 – represented a prototype of strains combining a
locus variant of O89 and group 1 capsular polysaccharide. Specifically, the variant
O89 locus in this strain was truncated at gnd, flanked by insertion sequences and
located between nfsB and ybdK and we apply the term O89m for this variant. The
prototype lacked colanic acid and O-antigen loci between yegH and hisI with this
tandem polysaccharide locus being replaced with a group 1 capsule (G1C) which,
rather than being a recognized E. coli capsule type, this locus matched to Klebsiella
K10 capsule type. A genomic survey identified more than 200 E. coli strains which
possessed the O89m locus variant with one of a variety of G1C types. Isolates from our
collection with the combination of O89m and G1C all displayed a mucoid phenotype
and E. coli 26561 was unusual in exhibiting a mucoviscous phenotype more recognized
as a characteristic among Klebsiella strains. Despite the locus truncation and novel
location, all O89m:G1C strains examined showed a ladder pattern typifying smooth LPS
and also showed high molecular weight, alcian blue-staining polysaccharide in cellular
and/or extra-cellular fractions. Expression of both O-antigen and capsule biosynthesis
loci were confirmed in prototype strain 26561 through quantitative proteome analysis.
Further in silico exploration of more than 200 E. coli strains possessing the O89m:G1C
combination identified a very high prevalence of multidrug resistance (MDR) – 85%
possessed resistance to three or more antibiotic classes and a high proportion (58%)
of these carried ESBL and/or carbapenemase. The increasing isolation of O89m:G1C
isolates from extra-intestinal infection sites suggests that these represents an emergent
clade of invasive, MDR E. coli.
Keywords: Escherichia coli, novel O-antigen, lipopolysaccharide, group 1 capsule, multidrug resistance (MDR),
quantitative proteomics
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INTRODUCTION
Escherichia coli is a much-studied bacterial species yet remains
incompletely understood. This is exemplified by E. coli’s
“open” genome such that – despite greater than 10,000
genome sequences (complete and incomplete) being readily
accessible – sequencing of any further isolates can be predicted
to add new content to the pan-genome (Rasko et al., 2008).
Additionally, this extent of genome sequence resource is leading
to identification of novel genomic features as well as providing
for systematic characterization of variable determinants
such as surface polysaccharides. These structures include
both lipopolysaccharide (LPS) and capsular polysaccharide
(CPS) which perform vital functions for bacteria both during
colonization of hosts and in the environment outside hosts.
Within the host, LPS O-antigen (also termed O-polysaccharide)
and CPS contribute to resistance to antibacterial defenses such
as complement and antimicrobial peptides as well as resistance
to phagocytosis (Miajlovic and Smith, 2014; Abreu and Barbosa,
2017). Some CPS types show strong fitness benefits, a notable
example being the E. coli K1 capsule which is frequent among
extra-intestinal E. coli (ExPEC). Parallels are seen in Klebsiella
for which CPS is a particularly important virulence determinant
(Clegg and Murphy, 2016; Paczosa and Mecsas, 2016). Hence,
LPS and CPS are described variously as fitness or virulence
factors.
At present, there are approximately 180 O-types, 80
K-types, and 50 H-types recognized among E. coli, relating
to O-antigen, capsule and flagella, respectively. Serotypes
are non-randomly distributed among E. coli with some
showing very strong associations with genotypes and pathotypes.
Notable exemplars include serotype O157:H7 which is the
archetypal enterohemorrhagic E. coli; serotype O104:H4 which
are major enteroaggregative strains (EAEC); and serotype
O25b:H4 (ST131) which has emerged as a pandemic ExPEC
lineage.
Developments of webtools such as SerotypeFinder for in silico
O:H typing of E. coli (Joensen et al., 2015) and Kaptive for in silico
capsule typing of Klebsiella (Wyres et al., 2016) allied to inter-
relatedness of serotype with pathotypic characteristics ensure that
the O:K:H system remains an informative classification scheme
for bacteria such as E. coli.
E. coli may produce any of four classes of CPS termed
groups 1–4 (Whitfield, 2006) plus colanic acid. Group 2 or 3
capsules (G2C or G3C) are the commonest types and strains
with these may also co-express with colanic acid; G4C (known
as O-antigen capsule) can also be co-expressed with colanic
acid and are widely distributed although they may be cryptic;
group 1 capsule (G1C) and colanic acid are mutually exclusive,
distinct systems. Highly mucoid phenotype may result from
substantial production of CPS or colanic acid and excessive
production of one or more surface polysaccharides can result in
a phenotype variously described as hypermucoid, mucoviscous,
or hypermucoviscous. Although these characteristics are more
typically identified in Klebsiella spp., some exceptional strains
of E. coli have been described, usually associated with particular
mutations (Jayaratne et al., 1993; Potrykus and Wegrzyn, 2004;
Zhang et al., 2008; Ionescu and Belkin, 2009; Van Tyne et al.,
2016).
Given the significance of LPS and CPS as major surface
structures in E. coli, Klebsiella, and other Gram-negative
bacteria, it is unsurprising that they have been the subject of
much investigation. Nonetheless, our investigations of multidrug
resistant (MDR), ESBL-producing E. coli have identified a
novel organization in the O-antigen locus. This arrangement
is invariably combined with other genomic re-organizations
which incorporate carriage of G1C loci. Proteomics and direct
examination of cellular polysaccharides confirmed expression
of both O-antigen and G1C. Survey of genome sequences and
associated metadata show that E. coli strains with combinations
of this novel O-antigen locus and G1C are geographically
widespread and carry a high number of antibiotic resistances
including ESBL, carbapenemases and MCR (colistin) resistances.
Many recent isolates of this type have been from extra-intestinal
samples, suggesting that this may be an emergent MDR clade
to which we must be alert. This investigation adds further to
our understanding of the adaptability of E. coli and the need to
remain vigilant to continued evidence of novel characteristics
of this deeply studied yet seemingly continuingly variable
bacterium.
RESULTS
E. coli 26561 Exhibits a Mucoid and
Viscous Phenotype
Escherichia coli strain 26561 has been described previously as an
ESBL-producing, MDR isolate (Dahmen et al., 2013). Culture of
26561 on a range of agar media revealed a colony characteristic
that resembled the “hypermucoviscous” (HMV) phenotype
displayed by certain Klebsiella pneumoniae strains (Fang et al.,
2004; Lee et al., 2006) which presents as a mucoid “string” of
≥5 mm adherent to a microbiological loop. An example of this
characteristic is shown in Figure 1. A panel of reference strains
(including MG1655, NCTC12241, NCTC9089, NCTC11107) did
not exhibit either mucoidy or viscosity although strains with the
same combination of O-antigen and CPS class as 26561 (see
following sections) all displayed mucoidy.
During routine handling of 26561 it was evident that it was not
possible to pellet the cells efficiently even under centrifugation
conditions of 10 min at 15,000 × g suggestive of production
of highly viscous extracellular polymer. A simple assay (Lai
et al., 2003; Cheng et al., 2010) was then adopted for relative
quantitation of viscosity. A panel of liquid media was assessed
and a similar profile of media-dependent relative viscosity was
evident. In all liquid media, non-mucoid strains as well as mucoid
but non-mucoviscous E. coli strains gave negligible relative
viscosity values (as defined in “Materials and Methods” section).
For E. coli 26561, viscosity assays showed three main groupings of
medium-dependent relative viscosity: LOW values were obtained
during growth in LB, TSB, MHB, and NB; MEDIUM values
were obtained by culture in PCB and DMEM-S; HIGH values
through culture in M9 minimal medium (with glycerol or glucose
as carbon source), MacConkey broth or DMEM-T. Frequently,
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FIGURE 1 | Escherichia coli strain 26561 displays a strong “string” effect
representative of hypermucoviscosity. This phenotype was evident on all agar
media on which this strain was grown and this is a representative image from
growth on LB agar.
relative viscosity in these media approached a value of 1, i.e.,
centrifugation failed to detectably pellet bacterial cells.
Influence of glucose availability on viscosity was further
explored in PCB and M9 media: although glucose concentration
affected bacterial yield, there was no dose-dependent effect on
relative viscosity. Several other parameters were assessed for their
effect on the mucoviscous phenotype of 26561: anaerobiosis,
growth temperature (37◦C, 24◦C, and c. 18◦C), iron or glucose
availability and growth phase showed no discernable influence
on mucoviscous characteristics as monitored by string test or
viscosity assay (data not shown). Treatment with DNAse also had
no effect on viscosity of 26561. A panel of other E. coli (including
several mucoid strains) lacked viscous phenotype under any
condition examined, hence E. coli 26561 was unique among this
panel in possessing mucoid and viscous characteristics.
Genomic Characterization and in silico
Typing
Mucoidy and mucoviscosity are typically conferred by expression
of extracellular polysaccharide materials. To identify and
characterize potential polysaccharide loci, genome sequencing
was carried out on both short-read and long-read platforms as
described in “Materials and Methods” section. From a hybrid
assembly, three contigs were obtained, the largest of which was
4.72 Mb in length with 27× coverage. The two smaller contigs
were 84,087 bases and 50,597 bases long, with coverages of 43×
and 64×, respectively. Each of these were resolved into circular
contigs by use of Circlator software (Hunt et al., 2015).
The assembled genome was confirmed as E. coli through
sequence comparison (BLAST) of the entire chromosome
sequence. Assembled contigs were submitted to the
PlasmidFinder1.3 database (Carattoli et al., 2014) which returned
matches (>98%ID) for plasmid replicons FIA, FIB, and IncQ1 to
the 84,087 base contig and a 100% match for IncFII to the 50,597
base contig. Submitting contigs to the ResFinder tool (Zankari
et al., 2012) which identified blaCTX-M-14 on the larger plasmid
and blaTEM-1, aph(3′′)-Ib/strA, aph(6)-Id/strB, aph(3′)-Ia, sul2,
and tetA(B) were carried on the smaller plasmid. Assembled
sequence indicated that catA1 was chromosomally encoded and
that this isolate is also resistant to quinolones (nalidixic acid,
enrofloxacin and ofloxacin) via substitutions in GyrA (S83L
and D87N) and ParC (S80I). This in silico characterization of
resistance genotype corresponded with previously reportedly
resistance phenotype (Dahmen et al., 2013) and specifies 26561
as a multidrug-resistant (MDR) isolate as defined by Magiorakos
et al. (2012).
Surface Polysaccharide Loci
Of the multiple surface polysaccharide structures potentially
carried by E. coli, we found loci for LPS, enterobacterial
common antigen (ECA), cellulose (pseudogenized), poly-N-
acetyl-glucosamine (PNAG) and two distinct capsule systems.
Capsular Polysaccharide
The known capsule types of E. coli are groups 1–4 and colanic
acid (Corbett and Roberts, 2008; Whitfield, 2009) of which the
most widely distributed is the latter. In the 26561 genome, we did
not identify colanic acid, group 2 or group 3 CPS loci although a
match was found to group 4 capsule (G4C – gfcABCDE-etp-etk).
Notably in 26561 this G4C locus appears to be intact and lacks
the interrupting insertion sequence present in the MG1655 genes
(Peleg et al., 2005).
In E. coli, the colanic acid locus is located in the genomic
region between yegH and hisI together with the gene cluster
which confers O-antigen biosynthesis (presented schematically
in Figure 2). In the 26561 genome sequence, the region
between yegH and hisI comprises twenty genes with functions
consistent with polysaccharide biosynthesis and transport, in
addition to hypothetical gene products and insertion sequence
elements (summary annotation is provided in Supplementary
Table 1A). Neither colanic acid nor O-antigen biosynthetic loci
were present, rather, this region featured genes typical of G1Cs,
specifically galF-hypothetical (PAP2) upstream of wzi-wza-wzb-
wzc-wbaP. Thus, colanic acid and adjacent O-antigen loci are
replaced by G1C, a scenario which is distinct from that previously
reported for other G1C-containing E. coli (Whitfield, 2009) in
which G1C replaces colanic acid adjacent to O-antigen locus.
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FIGURE 2 | Differences in the genetic organization between E. coli group 1 and colanic acid capsules. In both groups, capsule and O-antigen gene clusters are
located near the operon for histidine biosynthesis. In group 1 capsules, galF and a JUMPStart sequence (represented together as a diamond shape) are located
upstream of the capsule genes. The first structural gene of the capsule, wzi, is unique to group 1 capsules. By comparison, strains which produce colanic acid have
the galF and JUMPStart region upstream of the O-antigen. The final gene in the colanic acid locus is wcaM which is absent in group 1 capsule loci.
The prototypical G1C locus from E. coli strain E69 (serotype
O9a:K30:H12; accession AF104912.3) has been extensively
characterized over the past 30 years. This capsule locus sequence
spans approximately 16,000 bp from wzi to gnd and alignment
of G1C loci from E69 and 26561 is presented in Figure 3. This
comparison demonstrates conservation in assembly, transport,
membrane-anchoring and biosynthetic components (wzi, wza,
wzb, wzc, wbaP) and in the non-coding upstream region. The
divergence in sequences of glycosyl-transferases and other genes
encoded in the central region is indicative that the G1C type
(K-antigen) of 26561 is distinct from K30.
The genomic region of 26561 from galF to ugd (∼24,500 bp)
was used to search NCBI nucleotide collection and whole genome
shotgun contigs (WGS) databases (last searched November 2017)
resulting in no extensive matches to E. coli (40% coverage at most)
yet identifying four matches to Klebsiella with>90% identity over
>90% of sequence. Hence, this CPS locus is rare in E. coli and
appears to have been a relatively recent horizontal acquisition of
capsule from Klebsiella. The matching Klebsiella capsule typed
as K10 and the extent of identity between the 26561 locus is
presented in Figure 3. The terminology KP_K10 will be used to
distinguish from E. coli K-types.
O-Antigen Locus
Submission of the complete 26561 nucleotide sequence to the
SerotypeFinder database returned a result of serotype O89 by
matching of the wzt and wzm genes by 93.49 and 94.10% identity,
respectively. In the region encompassing galF-gnd, the O89 locus
is highly similar to O101 and O162 loci (DebRoy et al., 2016:
Iguchi et al., 2015) and the wzm and wzt sequences of 26561
show 92.6% and 93.4% identity, respectively, to those of both
O101 and O162. Locating the chromosomal position enabled
comparison of the O-antigen genomic region of 26561 to those
in the reference sequence for the O89-serotype locus. From an
initial inspection of the 26561 locus in Artemis, the first nine
genes (from galF) conformed to the published composition of the
O89 locus, although we noted that the 26561 sequence retained a
partial wcaM (the final gene of the colanic acid locus) and the
gnd gene was severely truncated (henceforth gnd#), both being
disrupted by insertion sequences. To examine differences further,
the whole genome reference sequence for O89 strains (strain
NCTC9089; European Nucleotide Archive SAMEA3403041) was
aligned with the corresponding region in 26561.
From the alignment (Figure 4 and further elaborated in
Supplementary Presentation 1) it became clear that there were
additional differences between these loci. Specifically, the two
genes preceding gnd#, annotated as a methyl-transferase and a
glycosyl-transferase, share only 47% and 42% amino acid identity
to their counterparts in NCTC9089 whilst BLAST searches with
the 26561 sequences show 100% matches to other proteins with
the same function in the NCBI database. Closer inspection of the
protein annotated as Gnd# in 26561, indicated that it is only 33
amino acids long, compared to 468 residues in the reference. In
addition to the premature stop codon, there is also a divergence
in the coding sequence: the first 22/33 amino acids are a 100%
match, but the remaining 10 amino acids – RALLNKSDFG – have
no match in the reference genome (Supplementary Table 1B lists
the genes from galF to gnd, their corresponding annotations and
identity in 26561). Of further note is a region downstream of gnd#
in 26561 which comprises two insertion sequences flanking three
short coding sequences which are annotated as putative Nlp-type
regulator, GNAT family N-acetyl transferase and a hypothetical
protein.
Divergence is also evident in the genes flanking the locus
in 26561 and the reference O89 genome. In the reference
the adjacent loci are colanic acid (wca) upstream and his
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FIGURE 3 | Alignment of group 1 capsule loci. (A) Prototypical E. coli group 1 capsule locus (ec_K30) aligned to capsule locus of strain 26561. The reference
sequence for E. coli K30 capsule (accession AF104912.3) spans 16,109 nucleotides comprising genes from wzi to the 5′ end of gnd. The alignment shown
corresponds to nucleotide identity of 73% between the first five genes; wzi-wza-wzb-wzc-wbaP, which are common to group 1 capsules. (B) Klebsiella NCTC 9130
is the reference strain for the Klebsiella K10 serotype. Shown is its nucleotide alignment to E. coli 26561 by BLAST with percent identities of the alignments
represented by the gradient shown on the right. The central region of the capsule locus is the most strongly conserved, with genes between wza and wbaZ (marked
by asterisks in the diagram) each sharing 99–100% identity. In 26561, an insertion sequence is present upstream of the first structural gene of the capsule, wzi, and
two are found after the last gene in the locus, ugd. (C) The upper row is a close-up of 26561, where the insertion sequences are present following ugd. A small
coding sequence of 54 amino acids is present downstream of the insertion sequences and upstream of the his operon. This is found to match 100% to the final 162
nucleotides of the E. coli O8 and O9 serotype reference sequences (bottom row; only O9 shown).
operon downstream, which is the expected arrangement for the
location of the O-antigen. In 26561 the insertion sequences that
bracket the locus are preceded by nfsB upstream and followed
by ybdK downstream. The genes upstream of nfsB include
those coding for copper/silver export; those downstream of
ybdK include the iron-acquisition genes conferring enterobactin
production. Aligning to the enterobactin-ybdK and nfsB-
copper/silver regions in E. coli MG1655 (lower section of
Figure 4) shows that these encompass ybdF and ybdJ,
two small hypothetical genes which are not present in
26561.
Taking into account (i) the truncation of O-antigen locus
(relative to conventional O89), (ii) sequence divergences within
remaining genes, (iii) foreshortening of wcaM and gnd,
(iv) juxtaposition of presumptive regulatory locus, and (v)
interspersion of insertion sequences, it seems probable that the
O-antigen in 26561 is a recent rearrangement into this novel
genomic context.
Expression of Polysaccharide
Biosynthetic Proteins
The atypical organization and location of polysaccharide
biosynthetic loci led us to conjecture whether LPS and CPS
were expressed. Corroboratory evidence was sought in a protein
expression dataset from 26561 (to be reported in full separately)
and direct analysis of cell-associated polysaccharide components
(see following section). As described in “Materials and Methods”
section, a Tandem Mass Tag (TMT) mass spectrometry approach
was used to assign and quantify protein expression. In matching
peptides to the 26561 protein database, we used only those
which matched uniquely to a given protein such that paralogs
(e.g., two GalF variants) could be distinguished from each other.
This proteome analysis detected a total of 53% (2451 of the
4577) potential proteins encoded by 26561 genome, providing
coverage similar to the upper range in other LC-MS/MS analyses
of unrelated E. coli clinical isolates (e.g., Pettersen et al., 2016,
2018; Møller et al., 2017).
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FIGURE 4 | Reference strain for E. coli serotype O89 (NCTC9089) aligned to O-antigen genes in E. coli 26561. The reference sequence for E. coli serotype O89 is
shown in the upper track. The black arrow marks galF and the start of the O-antigen locus with its remaining genes to ugd shown in green. The dark blue arrows
preceding galF represent the colanic acid locus. The wzm and wzt genes which are used for in silico serotyping by SerotypeFinder are labeled. Their nucleotides are
94.10% and 93.49% identical to the corresponding genes in E. coli 26561 (middle track). In E. coli 26561 we see that a partial wcaM (the final gene in the colanic
acid locus) is present but interrupted by an insertion sequence at its 5′ end (pink arrow: IS-1). The furthermost match is to the beginning of the gnd gene. The protein
coding sequences for the two genes preceding gnd, a methyl transferase and glycosyl transferase, are 47% and 42% identical, respectively, but are a 100% match
to other proteins with the same function in the NCBI database. The genes which flank the insertion sequences marked IS-1 and IS-3 in E. coli 26561 are nfsB and
ybdK. The bottom sequence illustrates that these genes are usually separated by two small hypothetical genes, ybdF and ybdJ, in E. coli K12_MG1655 (ybdJ is not
labeled in the diagram).
Evidence for expression of both capsular and O-antigen
loci from the proteome dataset is convincing; as illustrated in
Figure 5A, reporter intensities for the data as a whole span ∼5
orders of magnitude (range 3.1 × 106 – 3.6 × 1011), with the
average value for CPS (Figure 5B) and O-antigen (Figure 5C)
biosynthesis proteins (9.4 × 109) being toward the upper end
of this range. Of 38 coding sequences between the two loci,
11 are not detected as proteins. Of these, two are annotated
as ‘hypothetical’ proteins (1664 and 3126), four are transposon
proteins (1665, 3141, 3129, and 3125) and two are known to
be truncated (3140 – wcaM and 3130 – gnd). Of the three that
remain, (1667 – wzy, 1678 – AT, and 3135 – wzm) two are
small transmembrane proteins which are known to be difficult
to identify as they may be poorly solubilized and digested in the
sample preparation stages.
Tandem Mass Tag data were also examined for evidence of
expression of G4C (O-antigen capsule) system which comprises
seven gene products and has some similarities to G1C. Of the
G4C proteins, GfcE, Etp, and Etk (which are paralogous to G1C-
encoded Wza, Wzb, and Wzc, respectively) were detected by only
3, 2, and 3 peptides. This observation suggests that G4C makes
negligible – if any – contribution to the mucoid phenotype of
E. coli 26561 despite this locus being intact.
Hence, we can postulate that O-antigen and CPS biosynthetic
loci are functional and are presumably responsible for the
observed mucoid or mucoviscous phenotype. We further
investigated expression of LPS and CPS by several strains.
Characterization and Distribution of O89
O-Antigen and G1C Loci Among
Representative Complete E. coli
Genomes
An initial BLASTp search (December 2016) of the NCBI nr
database with the 33 amino acid Gnd# sequence of 26561
returned only one 100% match with the human intestinal
isolate E. coli MS-175. This had been assembled by short
read data which made it difficult to accurately compare to
26561. A contemporaneous search with the corresponding
nucleotide sequence returned five 100% matches (to strains
Sanji, H8, Y5, 6409, EC590) which had been sequenced by
PacBio to generate complete genomes. Genome sequences were
downloaded and submitted to SerotypeFinder: in each case the
O-type result returned was identical to that obtained for 26561,
i.e., serotype O89 with 94.10% ID to wzm and 93.49% ID to
wzt indicating that the 26561-like O89 locus may be present in
these strains. Sequences were annotated using the same program
and parameters as used for 26561, and O-antigen regions were
located. In each case the genes within the O-antigen and the
chromosomal location (between nfsB and ybdK) were identical to
that of 26561. Alignments of these loci from selected strains with
26561 O-antigen locus were performed thus confirming locus
content and organization (not shown).
In these completely sequenced strains we also investigated
the region around the his operon, identified in 26561 as the
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FIGURE 5 | (A) Plot displaying the range of reporter intensities for all 2451 proteins identified in E. coli 26561. (B) Expanded section of plot (A) detailing
identifications for proteins in the capsule region (y-axis). (C) Expanded section of plot (A) detailing identifications for proteins in the ‘O-antigen’ region (y-axis).
‘Summed Reporter Intensity’ (x-axis in all figures) represents the total signal detected from 10 TMT-labeled samples. tnp, transposon; GT, glycosyl-transferase; GH,
glycosyl-hydrolase; AT, acyl –transferase; MT, methyl-transferase; ‘gnd,’ truncated gnd.
location of G1C. A G1C-type locus was indicated in each by
the presence of wzi-wza-wzb-wzc-wbaP downstream of galF,
however, the remaining genes did not match the KP_K10 capsule
of 26561 or the prototype Ec_K30, nor did they match each
other. To our knowledge no tool exists for the typing of E. coli
capsules, however, more has been done to characterize Klebsiella
capsules genetically. The recently published tool, Kaptive (Wyres
et al., 2016) was created to predict Klebsiella capsule types
using short and long-read WGS data. Submitting our sequences
speculatively, we were surprised that in each case a Klebsiella
capsule type was returned which indicated close matches. We
obtained the relevant Klebsiella capsule sequences from NCBI
and performed alignments with each of the selected complete
genome sequences (Figure 6). In all selected genomes, the only
regions of non-alignment are to insertion sequences in the E. coli
strains which otherwise display high level of sequence similarity
to Klebsiella capsular loci.
In each of the six G1 capsule strains for which we performed
alignments we noted a variable number (one to seven) of coding
sequences between the transposon at the distal end of the capsule
locus (following ugd) and the his operon, in the region where
we would normally expect to find the O-antigen gene cluster
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FIGURE 6 | Group 1 capsule loci of representative E. coli ‘O89m’ strain capsule loci aligned to matching Klebsiella reference capsule sequences. Group 1 capsules
of O89m strains display high similarity to those in Klebsiella. The nucleotide sequences between the capsule (blue) and histidine (lime green) biosynthetic genes
match to the 3′ ends of either O8 or O9 O-antigen loci.
(Figure 6, green arrows). We extracted this region from each
sequence and found them to match O8 or O9 serotype loci
with high confidence (>99% nucleotide identity as summarized
in Supplementary Table 1C). In all instances, the initial genes
for O8 or O9 loci are absent. Notably, although O8 and O9
loci differ substantially from each other (Iguchi et al., 2015;
DebRoy et al., 2016) the final gene – mtfC – shares > 94%
identity over its entire length and is identical over the distal 150
nucleotides, therefore it is not possible to distinguish between
O-types O8 and O9 in which remnants are shorter than this.
Retention of variable content of residual O8/O9 locus sequences
further identifies the major genome reorganization events in
strain 26561 and other strains with the foreshortened O89 locus.
Characteristics of LPS and CPS
Expressed in 26561 and Other O89 E. coli
Strains
Given the atypical organization of O-antigen and capsular loci,
and the novel combination of O and K types in E. coli 26561 and
other O89m strains for which complete genomes are available,
we speculated whether both LPS and CPS were produced by
strains of this type. As indicated above, proteomics identified
biosynthetic proteins for both loci in prototypic strain 26561.
We sought corroboratory evidence by examining cellular and
extracellular polysaccharide production by a panel of O89 strains.
Specifically, we surveyed genome sequences from our strain
library and identified in our collection five additional strains all
possessing the same composition of O89m genes as 26561; none
of our isolates possessed a conventional O89 locus (summary
information for all O89 and O89m strains is provided in
Supplementary Data Sheet 1). Also examined were reference
strains for conventional O89 and O9 O-antigens, respectively,
NCTC9089 and NCTC11107.
O-antigen confers a “smooth” phenotype which is represented
by a “ladder” pattern when LPS is separated by polyacrylamide
gel electrophoresis (Figure 7 and Supplementary Figure 2).
Since the 26561-like O89m lacks several genes present in
“intact” O89 locus and since strains with this foreshortened
locus possess varying numbers of O8/O9 genes, this may affect
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FIGURE 7 | (A) Silver-stained gel of lipopolysaccharide preparations from a panel of O89m E. coli isolates and reference strains. Strains examined are: NCTC9089
(O89 reference strain) – lane 1; 26561/G246 – lane 2; C720825/G315 – lane 3; C021088_1/G189 – lane 4; C447731/G324 – lane 5; 2308/G76 – lane 6;
C232039_2/G310 – lane 7; NCTC11107 (O9 reference strain) – lane 8. With the exception of NCTC9089, strains showed a clear ladder pattern which was almost
indistinguishable among O89m strains and distinct from both reference O89 and O9 strains. Alcian blue-stained gels of cell-associated (B) and extracellular (C)
polysaccharides from a panel of O89m E. coli isolates and reference strains. Strains are: NCTC9089 (O89 reference strain) – lane 1; 26561/G246 – lane 2;
C720825/G315 – lane 3; C021088_1/G189 – lane 4; C447731/G324 – lane 5; 2308/G76 – lane 6; C232039_2/G310 – lane 7; NCTC11107 (O9 reference strain) –
lane 8. With the exception of NCTC9089, all other strains possess group 1 capsule loci and demonstrate staining of high molecular weight material in cell-associated
and extracellular samples.
LPS ladder pattern. Despite this, 26561 and similar O89m
strains all presented ladder patterns typical of smooth (O-
antigen-competent) LPS and which was clearly distinct from
that of both the O89 and the O9 reference strains. Therefore,
despite possessing an O-antigen locus terminating at gnd, intact,
“smooth” type LPS is produced.
Alcian blue staining of CPSs (Figures 7B,C) shows cellular
and extracellular polysaccharide preparations from the same
panel of strains. Among these only NCTC9089 lacks G1C.
Samples underwent exhaustive digestion with DNAse during
preparation of polysaccharides, thus the possible contribution
of DNA to this feature can be excluded. As anticipated from
matches to distinct Klebsiella CPS types, profiles of cellular and
extra-cellular polysaccharides varied among strains. It is also
notable that the two strains carrying KP_K10 capsule loci (26561
and C720825) show different profiles and distribution between
cellular and extracellular fractions inferring that strain-specific
determinants may contribute to polysaccharide synthesis and
surface presentation. Our initial genomic comparison of these
KP_K10 strains shows that chromosome content is highly similar
although incomplete genome restricts detailed comparisons.
Verification of these postulations will be subject to separate
investigation.
Characterization of Clade of O89- and
G1C-Positive E. coli Strains
Reports on E. coli O89 are rare, therefore we conducted a survey
(March 2018) of publicly available E. coli genome sequences
using nucleotide sequences representing entire O-antigen loci
from 26561 and NCTC9089 as well as individual coding
sequences and protein sequences from these strains. From this
survey, a total of 212 E. coli complete or WGS genomes were
identified (Supplementary Data Sheet 1). Surprisingly, among
these genomes, only ten (including NCTC9089) possessed a
region encompassing all 20 genes from wcaM to ugd whilst
the remainder terminated with a truncated gnd. Interestingly,
the 26561 region encompassing galF-gnd also matched at 99%
identity over 99% of the sequence to a genome identified as
Citrobacter braakii strain FDAARGOS_290 (GenBank accession
CP022049.1). In all instances matching 26561 sequence, the
predicted protein sequence for truncated gnd terminates
RALLNKSDFG, a motif that is restricted to C-terminal of twenty-
two diverse proteins from E. coli, Serratia, Enterobacter and
Klebsiella (last searched March 2018). O-serotype was cross-
validated using the SerotypeFinder tool with the result returned
in every case (including the C. braakii strain) was identical to
that obtained for 26561, i.e., serotype O89 with 94.10% identity to
wzm and 93.49% identity to wzt. In 25 complete E. coli genomes
matching O89m, upstream and downstream flanking genes to
this locus were identified as nfsB and ybdK.
From the E. coli O89 complete genomes examined to this
point, it is evident that this serotype determinant frequently
associates with G1C CPSs. To determine how consistent this
is as a feature of O89/O89m, genomes for these 212 strains
were surveyed for wzi/Wzi as a surrogate for G1C. Among the
212 O89-positive genomes, a total of 202 were identified which
also possessed G1C. Our survey also included a preliminary
assessment of general G1C distribution among the entire set
of available E. coli complete genomes which at the time of
sampling (February 2017) identified 197 wzi-positive E. coli
strains comprising O9 (n = 63; 32%), O8 (n = 31; 16%),
untypeable (n = 23; 11%); among these, O89 was predominant
(n = 80; 41%). A more extensive survey of wzi distribution among
E. coli is underway and detection of this gene may be a useful
adjunct in surveillance and diagnostic settings. As expected, O89
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strains possessing G1C lacked the locus encoding colanic acid
biosynthesis and were all of the 26561 O89m type. In contrast,
colanic acid-encoding strains all possessed the conventional O89
O-antigen locus (as for NCTC9089).
Further exploration by in silico typing of O89 strains identified
phylogenetic relatedness based on in silico prediction of STs –
157 of 202 O89m strains were identified as members of the ST10
complex (encompassing ST10, ST167, ST617, ST34, ST44, ST209,
and ST48; full information provided in Supplementary Data
Sheet 1). Despite close phylogenetic relatedness, these O89m
isolates originate from disparate geographic settings and include
commensal/fecal isolates as well as clinical isolates. Where
information is available regarding clinical status, 37.5% (63 of
168) were assigned an extra-intestinal origin (most frequently
blood, urine, and mastitis with ten further sites of origin).
Since prototype strain 26561 was originally identified as
ESBL-positive, multidrug resistant strain, all O89 strains were
assessed for carriage of transmissible resistance factors through
ResFinder. This revealed an exceptionally high prevalence of
accessory antibiotic resistances among O89m strains which was
supplemented through substitutions in GyrA, GyrB, ParE, and
ParC consistent with quinolone resistance. Greater than 95%
of O89m strains showed carriage of one or more accessory
resistance determinant compared to approximately 50% of
E. coli as an entire population (Goldstone and Smith, 2017).
Resistances for aminoglycosides, sulphonamides, tetracycline,
or β-lactams/cephalosporins were most common, each being
detected in>80% of O89m strains. Most (90%) O89m strains can
be classified as MDR (three or more resistances) and the mean,
median and modal values for resistance classes were 6, 7, and 8,
respectively. In contrast, O89 strains showed mean, median and
modal values of 1, 1, and 0, respectively, and for E. coli as an entire
population these values were 1.6, 0, and 0, respectively (Goldstone
and Smith, 2017). Among O89m isolates, 118 (58%) carried either
extended-spectrum β-lactamases (ESBLs) or carbapenemases of
CTX-M, CMY, SHV, NDM, KPC or OXA-48 classes. Sixty-three
carried one or more ESBLs, 6 carried carbapenemase, and 49
carried both ESBL and carbapenemase. No O89 strains carried
any of these resistances.
DISCUSSION
Escherichia coli is a well-studied bacterial species despite which
it remains incompletely understood, partly as a result of
its adaptability. This bacterium has adopted a diverse range
of lifestyles of which characteristics are conferred through
the flexibility in genome content. Diversity in genotype and
pathotype is reflected in classification schemes for E. coli and
the O:K:H system for O-antigen, capsule and flagella typing has
remained a mainstay. Systematizing gene content of bacterial
polysaccharide-biosynthesis loci presents significant challenges;
nonetheless, comprehensive categorization of E. coli O-antigen
loci (Iguchi et al., 2015; Joensen et al., 2015; DebRoy et al., 2016)
has been achieved. For E. coli, CPS loci remain to be similarly
categorized although the recently described systematization for
Klebsiella CPSs serves as a model (Wyres et al., 2016). Indeed,
some capsule types are common between Klebsiella and E. coli,
e.g., Klebsiella K20 (KP_K20) is equivalent to E. coli K30
(Ec_K30) and our study indicated that exchange of this locus
may extend further. These developments in in silico serotyping
ensure that the O:K:H system still represents an informative
classification scheme for E. coli.
O89-Encoding Genomic Loci Display
Two Distinct Variants Resulting From
Genomic Rearrangements
To date, E. coli of serotype O89 have been rarely reported (Füst
et al., 1977; Elekes et al., 1988; Hibberd et al., 1991; Yamamoto
et al., 1996; García-Aljaro et al., 2005; Dutta et al., 2011; Ahmadi
et al., 2012; Garza-Ramos et al., 2018), however, our survey
has identified more than 200 O89 strains among sequenced
genomes (complete and WGS). With E. coli 26561 as prototype,
inspection of the O89 locus and comparison with that of the
locus from reference strain NCTC9089 identified several notable
distinguishing features. Most evident were truncations of the
O-antigen locus in wcaM and gnd at either end of the locus
both of which were immediately adjacent to insertion element
sequences, indicative of genomic reorganization. The truncation
in gnd results in a predicted protein of 33 amino acids (in contrast
to 468 residues of wild-type Gnd), thus it can be predicted
that this gene is non-functional. Comparison of these truncated
sequences with O89 reference sequence from NCTC9089 showed
ten additional genes were present in reference O89 sequence
distal to gnd and ending with ugd. These encoded further
polysaccharide biosynthesis genes typical of O-antigen loci.
Inspection of over 212 other O89 strains showed that this
O-antigen locus truncation was common to the majority (>95%)
of these strains with only 10 of 212 retaining conventional O89
gene content – we use the term “O89m” for these truncated
variants. This assessment also revealed remnants of O-antigen
biosynthetic genes matching to either O9 or O8 types adjacent
to his locus, a site described as the location of O-antigen loci
in E. coli and confirmed in 100% of 573 Klebsiella strains
recently surveyed (Follador et al., 2016). In strains carrying
the conventional O89 type, the O-antigen locus was in the
expected sitting immediately downstream of colanic acid (which
is preceded by yegH) and upstream of his, whereas the location of
the O89m locus was between nfsB and ybdK genes. Although the
O89m locus mapped between nfsB and ybdK in the majority of
cases, there was a small minority of instances in which this was
not the case – these genomes are identified in Supplementary
Table 1D. In five of the strains (3c112, G188, G229, G233, G315),
the ybdK-ybdJ-ydbF-nfsB region was uninterrupted, indicating a
different site for the O89m locus. However, investigation of these
assemblies, which were highly fragmented, showed the O89m
genes to form short contigs bounded by insertion sequences
and so we were unable to link them to a location. A high
quality assembly (composed of only five contigs) is available
for the sixth of these strains, B41, in which the location of the
O89m locus was identified between tomB and dtpD. Interestingly,
of the of the ybdK-nfsB genes only ybdK was found in this
strain, indicating further genomic re-arrangements in B41. To
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our knowledge, these are only the second reported instances of
O-antigen localization in E. coli at novel genomic sites as was
recently noted for O62 (Hou et al., 2017). Taken together with the
flanking of this O89m O-antigen region with insertion sequences,
this is indicative of a major genomic reorganization event.
The More Prevalent O89 Variant Is
Associated With Carriage of Group 1
Capsule (G1C)
Further survey of genomes of O89m strains identified additional
polysaccharide loci including one encoding intact Gnd.
Interrogation of this locus identified it as encoding a G1C which
was distinct from the prototypic K30 G1C. Consistent with
previous reports (Amor and Whitfield, 1997), our initial survey
indicated that G1C-positive strains were commonly O9 (32%) or
O8 (16%) and a further 11% of strains comprised other O-types
or for which O-type could not be categorized. Significantly, the
most frequent O-type associated with G1C was O89m which
represented 41% of all G1C-positive E. coli strains.
Searching the sequence databases with the nucleotide
sequence of the 26561 G1C locus matched with Klebsiella capsule
type KP_K10. Intriguingly, many of the O89m genomes matched
with high confidence to Klebsiella capsule types with various
combinations of insertion sequences bracketing wzi to ugd.
Among O89m strains, the G1C gene cluster (regardless of K-type)
was located between yegH and his genes, the region which
is normally considered the location of colanic acid together
with O-antigen genes or G1C together with O-antigen genes
(as exemplified by E. coli O9a:K30:H12 strain E69). Taking
into consideration this group of approximately 200 O89m
E. coli strains, it is evident that major genomic reorganization
concurrent with genome island acquisition has taken place
among these strains. These events have involved replacement
of colanic acid and adjacent O-antigen loci between yegH and
his genes with G1C, an event that has occurred on multiple
occasions, introducing multiple capsule types with close identity
to those of Klebsiella spp. G1C acquisition was presumably
preceded by acquisition of the O89m locus – most frequently
by insertion between nfsB and ybdK which itself appears to be
a recent reorganization given the restricted distribution of these
events among E. coli.
O-Antigen and Capsular Polysaccharides
Are Expressed Despite Genomic
Rearrangements
Consequent to rearrangements in O-antigen and CPS loci
are truncation of gnd (6-phosphogluconate dehydrogenase,
decarboxylating) in the O-antigen locus and its presence in
intact form in the G1C locus. Although Gnd is non-essential
for E. coli viability, this enzyme plays a significant role in
metabolism (pentose phosphate pathway) which has knock-on
roles in fitness, notably as a substrate for several biosynthetic
pathways including polysaccharides (Jiao et al., 2003; Zhao et al.,
2004). Genome re-organizations have also resulted in acquisition
of two copies of galF (encoding a regulatory subunit for GalU,
glucose-1-phosphate uridylyltransferase); this redundancy and
divergence of galF is common across the G1C-carrying strains
examined. Taking strain 26561 as exemplar, the two copies of galF
show 77% identity at the nucleotide level and the corresponding
proteins are approximately 95% identical. Compared to GalF
of E. coli MG1655, the G1C-associated GalF and O-antigen-
associated GalF show 91% (273/299) and 95% (284/299) identity
in amino acid sequences, respectively. GalF has been shown to
interact with and modulate the function of GalU, glucose-1-
phosphate uridylyltransferase. Like Gnd, this enzyme performs
core metabolic roles and contributes to biosynthesis of surface
polysaccharides (Marolda and Valvano, 1996).
Given the novel combination of surface polysaccharides O89m
and KP_K10, the truncation and rearrangements between loci
and the unusual juxtaposition of these within core genome, it was
important to confirm production of both O-antigen and capsule.
Proteomics confidently detected in E. coli 26561 the majority of
proteins involved in CPS and O-antigen biosynthesis and export
and also as well as lipid-A and core biosynthetic proteins of
LPS. Gnd and both copies of GalF are expressed despite the
alterations affecting gnd and galF. The intact Gnd protein is the
most strongly expressed protein among all detected O-antigen
and capsule polysaccharide biosynthetic proteins. Expression of
both copies of GalF is of note although it is not apparent whether
they play redundant, complementary of competitive roles in
metabolism and polysaccharide synthesis.
Corresponding with protein expression, there appears to be
no evidence for deficit in surface polysaccharide expression or
composition. Visualization of LPS (Figure 7) from six O89m
strains show that they all exhibited a staining pattern typical
of “smooth” LPS with an obvious “ladder” of O-antigen repeat
units. All six O89m strains examined possess a G1C locus
and all displayed high molecular weight alcian blue-staining
polysaccharide in cell-associated, extracellular or both fractions.
Pattern varied among strains, consistent with the carriage
of distinct capsule types among these strains. Among these,
26561 was notable in production of a dense band of very
high molecular weight material in the extracellular fraction
with similar material just discernible in the cell-associated
fraction. It is presumed that this predominantly extracellular
polysaccharide is responsible for the profound mucoviscosity of
26561.
Proteomics also provided an opportunity to assess which
regulatory proteins associated with polysaccharide expression
were detected. LPS (lipid-A, core, and O-antigen) is an essential
surface structure and its expression is constitutive and as noted
above, G1C is reported as constitutively expressed. Expression of
both LPS and CPS loci may be subject to additional regulatory
control via alternative sigma factors, multiple signaling relays and
other regulators in response to growth status, envelope stress
and other cues. Important among these regulatory processes
are the Rcs regulatory cascade (Whitfield and Roberts, 1999)
and RfaH (Bailey et al., 1997), which is a transcriptional anti-
terminator which recognizes JUMPstart/ops sites and is reported
to play important roles in expression of long operons, particularly
surface or secreted structures including both LPS and CPS
expression. Among G1C-positive strains, both O-antigen and
capsule loci possess JUMPstart sequences sited, respectively,
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between galF and galE and between galF and wzi, consistent
with the participation of RfaH-JUMPstart in expression. Rcs
is a multicomponent regulator comprising core components
RcsB, RcsC, RcsD, and RcsF which were all detected in the
proteome as was RfaH. The proteins annotated as Nlp regulator
and acetyltransferase (sited along with a hypothetical protein
are located adjacent to O-antigen locus and are flanked by
insertion sequences in O89m genomes) were detected with
only low confidence and their expression as well as any
functional contribution will require independent investigation.
Acetyltransferases (ATase) integral to the Klebsiella K1 locus have
been shown to contribute to gene expression (Ho et al., 2011),
although as yet, roles of neither the Nlp regulator nor ATase
have been confirmed. We speculate that these gene products
participate in regulation of polysaccharide and/or other gene
expression.
Determinants regulating expression of O89m and G1C
and the extent of any potential regulatory interplay between
these polysaccharide loci have yet to be defined. Similarly,
determinants of the hypermucoviscosity of 26561 remain
to be specified and characterized experimentally. It will be
particularly significant to compare with other E. coli O89m
strains encoding KP_K10 capsule as well as characterizing among
wild-type E. coli isolates showing hypermucoviscosity to provide
comparison with Klebsiella. Further comparative and functional
genomics investigations will be required for verification of these
overlapping hypotheses.
Strains Possessing O89 and G1C Display
Mucoid or Hypermucoviscous Phenotype
Carriage of capsule typically confers a mucoid characteristic upon
strains and all G1C strains examined produced mucoid colonies
on several different agar media. Among the G1C strains, 26561
was distinct in exhibiting a mucoviscous phenotype. On agar
media strain 26561 was profoundly “string test” positive and in
liquid media 26561 proved strongly positive in a viscosity assay.
These characteristics are consistent with “hypermucoviscous”
phenotype displayed by some Klebsiella strains, most frequently
possessing capsular types KP_K1, KP_K2 or KP_K57. E. coli
26561 possesses capsule locus almost indistinguishable from
Klebsiella K10 (KP_K10) which has not to date been associated
with hypermucoviscosity. In Klebsiella, this phenotype has
also been correlated with capsule-enhancing regulators RmpA
and RmpA2 (Lai et al., 2003; Cheng et al., 2010), neither
of which is present in 26561 chromosome or either of its
two plasmids. This hypermucoviscosity also differs from the
enhanced mucoidy observed in some E. coli capsule (colanic
acid) regulatory mutants. Reports of E. coli with mucoviscous
phenotype are exceptional with only two previous clinical
reports of uropathogenic isolates although these isolates were
not characterized in detail (Bottone, 2010; Benham et al., 2013).
In the absence of detailed information for those strains, we
postulate that the hypermucoviscous phenotype of E. coli 26561
is conferred by determinants distinct from those required for
this characteristic in Klebsiella and from other hypermucoid or
mucoviscous phenotypes in E. coli.
As noted above, 26561 exhibits mucoviscous phenotype under
a broad range of growth conditions thus it is presumed that this
phenotype is not subject to measurable regulatory control under
the conditions examined. This is consistent with constitutive
expression of G1C reported by others. Although not reported in
E. coli, G1C expression in Klebsiella is subject to some regulatory
control by iron via Fur (Lin et al., 2011) and IscR (Wu et al., 2014)
although neither iron levels nor other environmental variations
affected production as assessed by viscosity assay. Whether E. coli
G1C is subject to additional regulatory inputs and whether this
varies from distinct G1C in E. coli or the equivalent capsule in
Klebsiella requires further investigation.
Taking together the preceding observations on
polysaccharides and their production in E. coli 26561 represent an
ideal opportunity for comparative investigation of determinants
of the mucoviscous genotype and phenotype.
O89m Distribution, Isolation Source, and
Multidrug Resistance (MDR)
Expanding from the prototypic O89m E. coli strain 26561 to
an extensive genomic survey identified that E. coli serotyped
in silico as O89 are more frequently O89m than conventional O89
serotype. Extensive population genomic analysis of O89m/O89
strains will be undertaken and reported separately. Only O89m
strains also possessed G1C whereas O89 strains possessed colanic
acid, consistent with the mutual exclusivity between these
polysaccharide loci. As a group, O89m strains tended to lack
conventional virulence factors.
Appraisal of available metadata (summarized in
Supplementary Data Sheet 1) indicated that a substantial
number of O89m strains have been isolated from invasive
infections (including urinary tract, pleural cavity, bloodstream,
mastitis, wound) or as antibiotic-resistant strains thus
circumstantially aligning these O89m:G1C strains to ExPEC
pathotype. Comprehensive categorization of acquired and
mutational resistances among O89 and O89m strains showed a
dearth of resistances among the former and a high preponderance
of resistance among the latter. Specifically, the O89 strains
typically carried zero or one resistance (although two O89 strains
can be categorized as multidrug resistant) whilst 89% of the
O89m strains can be categorized as MDR with these strains
carrying resistance to an average of six antibiotic classes. Carriage
of this magnitude of resistances resembles the accumulation
of resistances in ST131 strains (Pitout and DeVinney, 2017)
although it is unusual among the entirety of E. coli (Goldstone
and Smith, 2017).
The World Health Organization has identified ESBL- and
carbapenemase-producing E. coli (and other Enterobacteriaceae)
as high priority organisms hence we assessed presence of
these resistances in genome content. Profiling this characteristic
showed a similarly high density of ESBL, carbapenemase or
both among O89m strains. Additionally, approximately 1 in 8
(24 of 206) O89m strains carried the recently emerged mcr-
1 gene (Liu et al., 2016), indicative of resistance to colistin;
one additional strain carried a pmrB allele (Quesada et al.,
2015; Cannatelli et al., 2017) associated with colistin resistance.
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Two-way plots of features summarized in Supplementary Data
Sheet 1 are provided in Supplementary Figure 1. Taken together,
these plot permutations re-affirm the preponderance of O89m
strains compared with conventional O89 strains and the wide
geographical and host species distribution of O89m strains.
These plots also indicate an expansion of O89m from the early
2000s concurrent with (i) acquisition of G1C; (ii) accumulation
of multiple antibiotic resistances by mutation and horizontal
transfer; and (iii) increasing isolation from extra-intestinal sites.
Antibiotic resistances gained include ESBLs and carbapenemases.
In addition, 10% of O89m isolates carry a mcr gene conferring
resistance to colistin.
Resistance to antibiotics such as third generation
cephalosporins, carbapenems and colistin – considered as
“front-line” or “last resort” treatments – identifies O89m as
a possessing “pool” of priority resistances. Co-occurrence in
O89m strains of these high concern resistances with fitness and
virulence determinants such as CPSs in combination with the
increasing association of O89m strains with extra-intestinal
infections strongly suggest that these E. coli strains should be
considered as an emergent high risk clade requiring continued
monitoring.
MATERIALS AND METHODS
Bacterial Culture and MIC Determination
Bacterial isolates were stored at −80◦C in 20% v/v glycerol and
were revived by plating onto LB agar and growing overnight
at 37◦C in air. For each experiment, fresh working cultures
were prepared from frozen stocks. A range of solid and liquid
microbiological media were used including LB, MH, TSB, BHI,
NB, PCA, M9, and MacConkey. For some purposes, E. coli
were cultured in DMEM defined medium sourced from either
Sigma-Aldrich (DMEM-S; catalog number D6046) or Thermo
Fisher (DMEM-T; catalog number 11960). Routinely, growth was
carried out at a temperature of 37◦C and additionally at 24◦C
and room temperature (c. 18◦C) for assessment of mucoidy.
For anaerobic growth, culture was carried out using AnaeroGen
(Oxoid) or in an A35 Anaerobic Workstation (Don Whitley
Scientific, Shipley, United Kingdom) with a gas mixture of
hydrogen:carbon dioxide:nitrogen of 10:10:80. Where required,
iron availability was adjusted through supplementation with
FeSO4 (20, 40, 60, 80 or 100 µM final concentration) or
incorporation of dipyridyl (10, 20, 50, 100, 200 µM).
Genome Sequencing, Assembly, and
Annotation
Short-reads Assembly: DNA was extracted from an overnight
culture of Escherichia coli 26561 using MasterPureTM DNA
Purification Kit from Epicentre. Sequencing was performed
by Glasgow Polyomics using the MiSeq platform. Raw data
was assessed with FastQC1. Reads were pre-processed using
MyPro (Liao et al., 2015) prior to assembly using SPAdes
3.1.1 (Bankevich et al., 2012). The quality of the assembly was
1http://www.bioinformatics.babraham.ac.uk/projects/fastqc
evaluated using Quast (Gurevich et al., 2013). The assembled
genome consisted of 96 contigs (NG50 141, 083) with an average
coverage×15 and total length of 4.76 Mb.
Long-reads Assembly: DNA was extracted from a separate
culture of strain 26561 and sequenced using the PacBio platform.
Pbh5tools from Pacific Biosciences was installed locally and
bashh5tools used to extract subreads from the bax files in fastq
format. These reads were used in combination with the raw
sequence data from the MiSeq platform mentioned above [which
was this time pre-processed using ngsShoRT (Chen et al., 2014)]
to produce a hybrid assembly using SPAdes 3.9.1.
Assemblies were annotated using Prokka 1.12 (Seemann,
2014) and visualized in ARTEMIS. Coding sequences in regions
of interest were manually checked using BLAST and corrected
where appropriate. Visualizations of alignments between 26561
and other genomes were produced using ARTEMIS (Rutherford
et al., 2000) and EasyFig 2.2 (Sullivan et al., 2011).
Escherichia coli 26561 was previously sequenced in short reads
format and deposited at NCBI (BioSample SAMN04334740;
GenBank assembly accession GCA_001575995.1. Assemblies
generated from PaBio sequencing have been deposited as
BioProject SAMN08202527 with GenBank accession numbers
CP027118.1 (chromosome), CP027119.1 (86,731 bp plasmid) and
CP027120.1 (54,399 bp plasmid).
Escherichia coli Genomes and Genotypic
Characterization
This was carried out using a panel of webtools accessed via
Center for Genomic Epidemiology. Specifically, the tools used
were SerotypeFinder (Joensen et al., 2015), MLST typer (Larsen
et al., 2012), ResFinder (Zankari et al., 2012), and PlasmidFinder
(Carattoli et al., 2014). The panel of E. coli O89 genomes listed in
Supplementary Data Sheet 1 were sourced from NCBI.
Protein Sample Preparation and Mass
Spectrometry
A fresh colony of 26561 was used to inoculate 5 ml of
DMEM (Sigma D6046) and incubated overnight at 37◦C in
anaerobic conditions. From this point, to minimize fluctuations
in conditions, inoculation, incubation, centrifugation, and lysis
were all conducted in the same tube used for culture of each
replicate: In brief, 12 high-speed centrifuge tubes (Oak Ridge
PSF) were filled with 30 ml of warmed DMEM. Four were
supplemented with Ceftazidime (Sigma, C0690500, Batch 2,
200 mg. Eur.Pharma. Reference standard) to a concentration
of 0.15 µg/ml and another 4 to a concentration of 0.3 µg/ml
(respectively, approximately 1/4 and 1/2 MIC as determined under
experimental conditions used, i.e., DMEM under anaerobic
conditions).
Each was inoculated with 30 µl of the overnight culture
(1/1000 dilution). The cultures were incubated anaerobically at
37◦C for 6 h after which they were transferred immediately to
a pre-warmed (37◦C) high-speed centrifuge (Sigma 4K15) set at
13,500 rpm for 14 min (spin conditions established in prior tests
to determine minimum time for formation of pellets). The pellets
obtained were drained of media, and 2 ml lysis solution (100 mM
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Tris-HCL, pH 7.6 containing 4% SDS) was added. Samples were
incubated in lysis buffer for 10 min at 95◦C, vortexed, and then
flash frozen for immediate transfer to the proteomics facility on
dry ice. Prior to freezing, aliquots were retained for assay of
protein yield using Bio-Rad RC-DC (detergent-compatible) kit.
Yields were equivalent to approximately 1 mg/ml lysate and were
measured also by the proteomics facility.
Proteomic Analysis – TMT Labeling and
High pH Reversed-Phase
Chromatography
Aliquots of 100 µg of 10 samples per experiment were
digested with trypsin (2.5 µg trypsin per 100 µg protein;
37◦C, overnight), labeled with TMT10plex reagents according
to the manufacturer’s protocol (Thermo Fisher Scientific,
Loughborough, United Kingdom) and the labeled samples
pooled.
An aliquot of 50 µg of the pooled sample was evaporated to
dryness and resuspended in buffer A (20 mM ammonium
hydroxide, pH 10) prior to fractionation by high pH
reversed-phase chromatography using an Ultimate 3000
liquid chromatography system (Thermo Fisher Scientific). In
brief, the sample was loaded onto an XBridge BEH C18 Column
(130 Å, 3.5 µm, 2.1 mm × 150 mm, Waters, United Kingdom)
in buffer A and peptides eluted with an increasing gradient of
buffer B (20 mM Ammonium Hydroxide in acetonitrile, pH
10) from 0 to 95% over 60 min. The resulting fractions were
evaporated to dryness and resuspended in 1% formic acid prior
to analysis by nano-LC MSMS using an Orbitrap Fusion Tribrid
mass spectrometer (Thermo Scientific).
Nano-LC Mass Spectrometry
High pH RP fractions (total proteome analysis) or phospho-
enriched fractions (phospho-proteome analysis) were further
fractionated using an Ultimate 3000 nanoHPLC system in
line with an Orbitrap Fusion Tribrid mass spectrometer
(Thermo Scientific). In brief, peptides in 1% (vol/vol) formic
acid were injected onto an Acclaim PepMap C18 nano-trap
column (Thermo Scientific). After washing with 0.5% (vol/vol)
acetonitrile 0.1% (vol/vol) formic acid peptides were resolved on
a 250 mm× 75µm Acclaim PepMap C18 reverse phase analytical
column (Thermo Scientific) over a 150-min organic gradient,
using seven gradient segments (1–6% solvent B over 1 min, 6–
15% B over 58 min, 15–32% B over 58 min, 32–40% B over
5 min, 40–90% B over 1 min, held at 90% B for 6 min and then
reduced to 1% B over 1 min) with a flow rate of 300 nl min−1.
Solvent A was 0.1% formic acid and Solvent B was aqueous 80%
acetonitrile in 0.1% formic acid. Peptides were ionized by nano-
electrospray ionization at 2.0 kV using a stainless-steel emitter
with an internal diameter of 30 µm (Thermo Scientific) and a
capillary temperature of 275◦C.
All spectra were acquired using an Orbitrap Fusion Tribrid
mass spectrometer controlled by Xcalibur 2.0 software (Thermo
Scientific) and operated in data-dependent acquisition mode
using an SPS-MS3 workflow. FTMS1 spectra were collected
at a resolution of 120,000, with an automatic gain control
(AGC) target of 200,000 and a max injection time of 50 ms.
The most intense ions were selected for MS/MS. Precursors
were filtered according to charge state (to include charge states
2–7) and with monoisotopic precursor selection. Previously
interrogated precursors were excluded using a dynamic window
(40 s ± 10 ppm). The MS2 precursors were isolated with a
quadrupole mass filter set to a width of 1.2 m/z. ITMS2 spectra
were collected with an AGC target of 5000, max injection time of
120 ms and CID collision energy of 35%.
For FTMS3 analysis, the Orbitrap was operated at 60,000
resolution with an AGC target of 50,000 and a max injection time
of 120 ms. Precursors were fragmented by high energy collision
dissociation (HCD) at a normalized collision energy of 55% to
ensure maximal TMT reporter ion yield. Synchronous precursor
selection (SPS) was enabled to include up to five MS2 fragment
ions in the FTMS3 scan.
Protein Identification and Quantification
MaxQuant 1.5.7.4 (Tyanova et al., 2016a) was used to
identify proteins from the raw MS files. The 4577 protein
sequences from our 26561 hybrid assembly, together with the
contaminant sequences provided by MQ, were used to form
the search database. Modifications were selected as ‘fixed’ for
Carbamidomethyl and ‘variable’ for Oxidation (M) and Acetyl
(Protein N-term). Phospho (STY) was added as ‘variable’ for
the files related to phospho-enriched samples. The reporter
ion was MS3, TMT10plex, with a reporter mass tolerance of
0.01 D. The digestion mode was trypsin with two missed
cleavages permitted. The PSM and Protein FDR was 1%. Only
peptides mapping uniquely to one protein sequence were used
for quantification. Data was further processed and analyzed using
Perseus 1.5.5.0 (Tyanova et al., 2016b). Data are available via
ProteomeXchange with identifier PXD008339 and a summary of
the relevant peptides and protein identification data is provided
as Supplementary Data Sheet 2.
Viscosity Assay
This utilized a simple centrifugation-based assay to quantify
bacterial sedimentation at low centrifugal force (Lai et al., 2003;
Cheng et al., 2010). Briefly, standardized inocula were prepared
in medium and cultured overnight (18–20 h). Total growth
was monitored by measuring absorbance at a wavelength of
600 nm (A600); aliquots were placed into 1.5 ml microcentrifuge
tubes and centrifuged (1,000 × g; 4◦C; 5 min). Tubes were
carefully handled to minimize mixing and the upper 1 ml of
liquid was gently aspirated into a pipette tip and dispensed into
microcuvettes for A600 measurement. The ratio of A600 for post-
centrifuged (lower value) to the pre-centrifuged (greater value)
was calculated to estimate relative viscosity. Relative viscosity
values of <0.2 were categorized as “negative”; LOW values as
0.2–0.35; MEDIUM values as 0.5–0.8, and HIGH values as >0.8.
Cellular and Extra-Cellular
Polysaccharide Preparation
E. coli for LPS and CPS preps were cultured overnight at 37◦C.
The LPS and CPS were extracted as described previously by
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Hitchcock and Brown (1983), with modifications of Geisinger
and Isberg (2015) to reduce nucleic acids content in
the sample preps. Cellular polysaccharides were extracted
from cell pellets and extracellular polysaccharides from
supernatants after centrifugation at 15,000 × g for 10 min
(which is required to sufficiently sediment 26561). Silver
staining was performed using Bio-Rad silver stain kit
(catalog number 1610443), according to manufacturer’s
instructions. Alcian blue staining (8GX, Alfa Aesar, Fisher
Scientific, catalog number 15432949) was performed
according to methodology described by Mercaldi et al.
(2008).
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